Not hard to see you got caught short... you've made like 10 posts tonight of nonsense.
sorry about the all caps everyone, I keep seeing it from other people, thinking its annoying, so I tried it, and it is annoying, won't do it again, unless I have to
Sentiment: Strong Buy
It is not Kain's fault. This was all clearly known up front. Just look at the history of Mortgage REIT's, or look up my older posts from 2-3 years ago. Never stay in a M-REIT more than 5 years, 3 years is the optimum. M-REIT's only raise capital when rates are low and amateur Yield Investor are aplenty. Classic pattern from the 1970's, 1980's, 1990's, 2000's, the people who make big bucks from M-REIT's are the underwriters and the management companies earnings the 1-2% commish on invested assets, who cares about the leverage or the debt, as long as assets are growing or high, the commish will be high.
These guys have been delivering solid wins all year, ready to see what they find next.
In the year 2525, if man is still alive.
If women can survive.
They may find SPY 213.
Then in the year 3535
If the FED does do survive
You're right - tons of headlines - too bad they are all bad - hahahaha!!!
I believe the question is ,, When is Ambr. Un... dressing.
and the answer is always!.
Sentiment: Strong Buy
So I am going to take a stab at numbers from what we know on anticipated sales of Afrezza. Please feel free to correct me if I am assuming something wrong.
1. We know we will have 3 lines soon capable of producting 360M cartridges - 10% InventoryEstimate
2. We know each box has 90 (a month's supply) - 3 meals x 3 days and each box costs roughly $250 retail - $50 = $200 approx wholesale price
3. 324M/90=3.6M boxes x $200 (wholesale) = $720M sales price for 324M boxes
4. We assume each diabetic patient utilizes roughly 3 cartridges a day, 90 a month x 12 months= or 1080 cartridges
5. For selling 324M cartridges with each diabetic utilzing roughly 1080 per year, we are talking about
324M/1080 = 0.3M or 300,000 patients
6. We don't know the costs of manufacturing Afrezza, but I will assume 1/3 or wholesale price? or say $220M for 324M cartridges?? - total assumtion here-- so we are left with profit of $500M approx...
7. We also know Sanofi eats 65% and Mannkind gets 35% which translates to $175M revenues you subtract the 35% of costs that Mannkind spends in the manufacturing (35% of 220M) = $75M
So in all told Mannkind is expected to make about $100M in profit for year # 1
Am I correct??
They've been delivering great results all year, best reports out there no question about it.
REALLY ! Is that why 30 days ago March 30, the PPS was $8.57 and today April 30 the PPS is Up.....MAKE THAT DOWN $7.91
DO you like losing money ? You're the only one that thinks there the "BEST REPORTS OUT THERE" I guess everybody else is wrong and you're the only one right. You're REALLY going to enjoy the 53% loss for next quarter which is posted here on the Yahoo projections for growth, check it out.
mgm is not me bro... I am new to idea. I just put in a a new position this month because i thought it was oversold at $3.30 and i was wrong..I should have waited when it crossed the 200 sma downward but I am long so it won't matter...hope to get more shares around $2.50 if it ever reach that level
"When you do what I do for a living you have to have a positive mental attitude; when that positive mental attitude isn't enough to get you across that jump you have to be man enough to deal with the circumstances. In my case, I'm man enough."
I don't see how they pass the Nasdaq small cap director requirements going forward. I notice a bullish poster here suggesting this is a positive development and would like to know why. The only thing I can think of as a long suffering shareholder is with Glenn's departure, CC denial of uplisting interest, and total tail wagging the dog via debt holders, we all #$%$ and a single step away from class action for breath of fiduciary responsibility ...and this denotes something, anything ...suggesting... restructure is coming. I just cannot connect those dots.
Smells like those leaving want to protect themselves from litigation. And smells like platinum is after their 15% going forward (less likely now without mgmt team in place)...or... assumption of patents through bankruptcy (then sale leaving common shareholders with nothing.) The latter being something I dismissed for years understanding the real $$$ was them uplisting and dumping shares to bigger investment community.
Please, only serious opinions here. What am I missing? Why could board departures be good?